Related Experiment Videos
Imaging modalities in central nervous system systemic lupus erythematosus
T W Huizinga1, S C Steens, M A van Buchem
1Department of Rheumatology and Department of Radiology, Leiden University Medical Center, Leiden, The Netherlands. t.w.j.huizinga.reuma@lumc.nl
Current Opinion in Rheumatology
|October 18, 2001
Summary
A new case definition system for central nervous system systemic lupus erythematosus (CNS-SLE) aids research. Imaging reveals diffuse brain processes, axonal damage, and atrophy in CNS-SLE patients, with MRI being the preferred diagnostic tool.
Area of Science:
- Neurology
- Immunology
- Radiology
Background:
- Established case definitions for central nervous system systemic lupus erythematosus (CNS-SLE) enable consistent research.
- Previous studies often lacked standardized criteria for CNS-SLE patient cohorts.
Purpose of the Study:
- To summarize current understanding of CNS-SLE pathophysiology and diagnostic approaches.
- To highlight the role of advanced neuroimaging in diagnosing and characterizing CNS-SLE.
Main Methods:
- Review of recent studies utilizing standardized CNS-SLE case definitions.
- Application of advanced neuroimaging techniques, particularly cranial magnetic resonance imaging (MRI).
- Analysis of imaging findings in CNS-SLE patients, differentiating active disease from residual effects.
Main Results:
- Standardized case definitions facilitate cross-study comparisons in CNS-SLE research.
- Neuroimaging in CNS-SLE patients without infarctions suggests a diffuse cerebral process.
- This diffuse process is linked to axonal damage, demyelination, and cerebral atrophy.
- Cranial MRI is identified as the primary diagnostic imaging modality for neuropsychiatric symptoms in SLE.
- Quantitative MRI may differentiate active CNS-SLE from residual neuropsychiatric symptoms.
Conclusions:
- Standardized case definitions have advanced CNS-SLE research.
- Diffuse brain pathology, axonal damage, and atrophy characterize CNS-SLE.
- Cranial MRI is crucial for diagnosing CNS-SLE, with quantitative techniques showing promise in distinguishing active disease.